Skip to content

IDEAYA Biosciences, Inc. IDYA Other Income (Expense)

Other Income (Expense) at other companies

Amgen logo
AmgenAMGN
$75M-95.1%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$3.26M+21.1%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$6M-40.0%
Erasca, Inc. logo
Erasca, Inc.ERAS
$4.47M-4.1%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$5.3M-32.1%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$5.79M+47.0%

Other financials

Income statement

See full
Revenue$6.6M
Operating income-$108.5M-28.6%
Net income-$98.5M-36.5%
EPS (diluted)-$1.11-35.4%

Balance sheet

See full
Cash & equivalents$157.5M+21.2%
Total debt$28.6M+10.1%
Total equity$937.3M-8.5%
Total assets$1.0B-6.4%

Cash flow

See full
Operating cash flow-$75.2M-24.6%
CapEx$967.0K-27.3%
Free cash flow-$76.1M-23.5%

Valuation

See full
Market cap$3.36B+104%
Enterprise value$3.23B+110%
P/S14.5×+9.9×

Profitability

See full
Operating margin-4,671.1%-5,434pp
Net margin-3,921.1%-4,562pp
FCF margin-3,592%-4,290pp

Returns & leverage

See full
Return on equity-14.3%-5.0pp
Debt / equity0.0×
Current ratio10.7×-3.2×

Where this comes from

Reported directly by IDEAYA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IDEAYA Biosciences, Inc.'s other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IDEAYA Biosciences, Inc.'s other income (expense)?
IDEAYA Biosciences, Inc. (IDYA) reported other income (expense) of $10.01M in Q1 2026.
How has IDEAYA Biosciences, Inc.'s other income (expense) changed year-over-year?
IDEAYA Biosciences, Inc.'s other income (expense) decreased by 18.1% year-over-year, from $12.21M to $10.01M.
What is the long-term trend for IDEAYA Biosciences, Inc.'s other income (expense)?
Over 4 years (2021 to 2025), IDEAYA Biosciences, Inc.'s other income (expense) has grown at a 208.1% compound annual growth rate (CAGR), from $506K to $45.62M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.